# Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain

> **NCT00414349** · PHASE3 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 431 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Topical analgesic
- **DRUG:** oral intake
- **DRUG:** Topical analgesic

## Key facts

- **NCT ID:** NCT00414349
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-03
- **Target enrollment:** 431 (ACTUAL)
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414349, "Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00414349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*